Headline
The latest stories from AHA Today.
The U.S. Court of Appeals for the Eleventh Circuit issued its opinion explaining why it denied Florida’s motion for an injunction pending appeal.
The Centers for Medicare & Medicaid Services intends to propose adding a “birthing-friendly” hospital designation on its Care Compare website to drive improvements in perinatal health outcomes and maternal health equity, the Department of Health and Human Services announced.
The White House hosted a summit to mark the first federal Maternal Health Day of Action. The summit highlighted actions the federal government is taking to reduce maternal mortality and morbidity.
In recognition of National Influenza Vaccination Week, AHA is partnering with the Centers for Disease Control and Prevention on a series of resources encouraging families to take steps to protect themselves and their loved ones from seasonal flu and remind everyone that still needs to get…
The Centers for Medicare & Medicaid Services will host a Special Open Door Forum Dec. 8 at 2 p.m. ET on provider requirements effective Jan. 1 under the No Surprises Act.
A legislative package could be voted on in the House that would stop upcoming Medicare cuts to hospitals, physicians and other providers that are scheduled to kick in early next year.
Learn how hospital and health system leaders such as Brian Miller, M.D., chief medical informatics officer and vice president of the Telehealth Institute at ProMedica Health System, are using artificial intelligence and other technology to improve quality and manage population health through early…
AHA issued a statement on the legacy of former Senate Majority Leader Bob Dole, R-Kan., following his death at age 98.
The number of Medicare visits conducted through telehealth surged 63-fold during the pandemic, from about 840,000 in 2019 to 52.7 million in 2020, according to a report released by the Department of Health and Human Services.
The Food and Drug Administration authorized administering bamlanivimab and etesivimab together to treat or prevent COVID-19 in all pediatric patients exposed to or testing positive for the virus who are at high risk for progressing to severe disease.